Microbiology & Virology Market Research Reports & Industry Analysis
One of the main focuses in virology is the study of viral infectious diseases including: rhinoviruses (common cold), influenza (flu), Herpes (simplex, zoster and varicella-zoster), AIDS (autoimmune deficiency virus), Human Papillomavirus (HPV), rabies and measles.
Some viruses, known as oncoviruses, are known to be cancer causing. The most widely studied example is the link between HPV, a sexually transmitted virus, and cervical cancer.
There are more then 150 strains of HPV, over 40 of which are sexually transmitted. Certain types of “high-risk” sexually transmitted HPV viruses can lead to cell mutations and cause cervical cancer as well as cancer of the vagina, vulva, penis and anus. Research shows that these high-risk HPV viruses cause over 99% of cervical cancers.
According to the National Cancer Institute, it is estimated that in 2010 about 12,000 women in the United States were diagnosed with cervical cancer and more than 4000 would die from it.
Although there are no treatments available for HPV, the FDA approved Cervarix and Gardisil, vaccines used to protect against the types of HPV that most commonly cause cervical cancer.
Microbiology & Virology Industry Research & Market Reports
-
Global Tuberculosis (TB) Diagnostics Competitive Landscape Professional Research Report 2024
... (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Competitive Landscape Professional Research Report 2024
... the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis ... Read More
-
Global Tuberculosis (TB) Detection Competitive Landscape Professional Research Report 2024
... methods are used for TB detection depending on the suspected type of infection and the resources available. Common TB detection methods include tuberculin skin tests (TST), also known as Mantoux tests, where a small amount ... Read More
-
Global Lyme Disease Testing Competitive Landscape Professional Research Report 2024
... Borrelia burgdorferi. The primary method of Lyme disease testing involves serological tests that detect antibodies produced by the immune system in response to the infection. The most common serological tests include the enzyme immunoassay (EIA) ... Read More
-
Legionella Testing Market Assessment, By Test Type [Urinary Antigen Tests, Direct Fluorescent Antibody Tests, PCR, Culture Method, Others], By Applications [Environmental Testing, Clinical Testing], By End-User [Hospitals, Clinics, Diagnostic Laboratories, Water Treatment Plants, Others], By Region, Opportunities and Forecast, 2017-2031F
... Region, Opportunities and Forecast, 2017-2031F Global legionella testing market is projected to witness a CAGR of 7.51% during the forecast period 2024-2031F, growing from USD 351.3 million in 2023 to USD 627 million in 2031F. ... Read More
-
Infectious Disease Diagnostics Market Forecasts to 2030 – Global Analysis By Product (Assays & Reagents, Kits, Consumables, Instruments and Software & Services), Disease (Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections and Other Infectious Diseases), Technology (Immunodiagnostics, Microbiology, Polymerase Chain Reaction, Next-generation Sequencing and Other Technologies), End User and By Geography
... Technology (Immunodiagnostics, Microbiology, Polymerase Chain Reaction, Next-generation Sequencing and Other Technologies), End User and By Geography According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $23.63 billion in 2024 and is ... Read More
-
Sexually Transmitted Disease Diagnostics Market by Disease Type (Bacterial Vaginosis, Candidal Vaginitis, Chlamydia Trachomatis/ Neisseria Gonorrhoeae), Diagnostic methods (Antigen Detection, Molecular Diagnostics, Serologic Testing), Device Type, End-Use
... Diagnostics Market size was estimated at USD 106.53 billion in 2023 and expected to reach USD 112.56 billion in 2024, at a CAGR 5.97% to reach USD 159.97 billion by 2030. Sexually transmitted disease diagnostics ... Read More
-
Industrial Microbiology Market by Product Type (Consumables, Equipment & Systems, Laboratory Supplies), Test Type (Bio-Burden Testing, Microbial Limits Testing, Sterility Testing), Application - Global Forecast 2024-2030
... 17.06 billion in 2023 and expected to reach USD 18.41 billion in 2024, at a CAGR 8.11% to reach USD 29.46 billion by 2030. Industrial microbiology involves the use of microorganisms for the production of ... Read More
-
Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Global Forecast 2024-2030
... expected to reach USD 8.68 billion in 2024, at a CAGR 10.91% to reach USD 16.12 billion by 2030. Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of ... Read More
-
Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 52.51 billion in 2024, at a CAGR 7.22% to reach USD 79.95 billion by 2030. The infectious diseases in-vitro diagnostics market comprises devices, consumables, and services used to detect ... Read More
-
Rapid Microbiology Testing Market by Product (Consumables, Instruments, Reagents & Kits), Method (Cellular Component-Based Rapid Microbiology Testing, Growth-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing), Application, En
... Testing Market size was estimated at USD 4.53 billion in 2023 and expected to reach USD 4.86 billion in 2024, at a CAGR 7.54% to reach USD 7.54 billion by 2030. Rapid microbiology testing is ... Read More
-
Sepsis Diagnostic Market by Testing Type (Laboratory Testing, PoC Testing), Technology (Flow Cytometry, Immunoassays, Microbiology), Product, Method, Pathogen, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 611.80 million in 2024, at a CAGR 9.98% to reach USD 1,084.17 million by 2030. Sepsis diagnostics refers to the variety of procedures and tests used to identify and ... Read More
-
Genetic Testing Market by Product (Consumables & Equipment, Software & Services), Test Type (Carrier Testing, Diagnostic Testing, New Born Screening), Technology, Application, Distribution Channel, End-User - Global Forecast 2024-2030
... estimated at USD 11.89 billion in 2023 and expected to reach USD 13.55 billion in 2024, at a CAGR 14.01% to reach USD 29.79 billion by 2030. Genetic testing comprises a diverse range of products ... Read More
-
Water Testing Market by Product (Colorimeter, Conductivity Meter, Conductivity Sensor), Pathogen Type (Clostridium, Coliform, Legionella), Product Type, Application - Global Forecast 2024-2030
... and expected to reach USD 10.15 billion in 2024, at a CAGR 7.33% to reach USD 15.54 billion by 2030. Water testing includes equipment and kits used for analyzing the quality of water in various ... Read More
-
Global Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... Regional Forecasts 2022-2032 Global Laboratory Developed Tests Market is valued at approximately USD 12.36 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.21% over the forecast period ... Read More
-
Asia Pacific Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... and Regional Forecasts 2022-2032 Asia Pacific Laboratory Developed Tests Market is valued at approximately USD 3.58 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.20% over the ... Read More
-
Europe Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... Regional Forecasts 2022-2032 Europe Laboratory Developed Tests Market is valued at approximately USD 2.60 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.63% over the forecast period ... Read More
-
US Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032.
... Regional Forecasts 2022-2032. US Laboratory Developed Tests Market is valued at approximately USD 3.47 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period ... Read More
-
Nosocomial Pneumonia – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Nosocomial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Nosocomial Pneumonia market report provides current treatment practices, emerging drugs, Nosocomial ... Read More
-
Pneumonia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pneumonia market report provides current treatment practices, emerging drugs, Pneumonia market share of the individual ... Read More
-
Liver Disease Therapeutic Market Report by Therapy Type (Anti-Rejection Drugs/Immunosuppressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulins, Corticosteroids, and Anti-Viral Drugs) Disease Type (Non-alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis (B, C, D), Alcoholic Liver Disease (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032
... (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032 The market for Liver Disease Therapeutics is predicted to reach US$ 28.98 billion in 2032, increasing at a ... Read More
-
Lyme Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Lyme Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Lyme Disease market report provides current treatment practices, emerging drugs, Lyme ... Read More
-
Syphilis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Syphilis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Syphilis market report provides current treatment practices, emerging drugs, Syphilis market share of the individual ... Read More
-
Tuberculosis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Tuberculosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Tuberculosis market report provides current treatment practices, emerging drugs, Tuberculosis market share of the individual ... Read More
-
United States Molecular Diagnostics Market Report by Technology (Chips and Microarrays, In Situ Hybridization, Sequencing, Mass Spectrometry (MS), PCR, and Other Technologies), Application (Pharmacogenomics, Infectious Disease, Genetic Disease Screening, Oncology, Blood Screening, Microbiology, and Human Leukocyte Antigen Typing), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Company Analysis 2024-2032
... Leukocyte Antigen Typing), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Company Analysis 2024-2032 The United States Molecular Diagnostics Market was US$ 7.98 billion in 2023 and will ... Read More
Research Assistance
